Abstract
Many antihypertensive drugs have adverse effects on glycemic control when they are used in diabetic patients. This was noted for thiazide diuretics in 1960, and the mechanism of the effects remains uncertain. Indirect evidence suggests that changes in the serum potassium are at least contributory, although the principal mechanism of thiazide-induced hyperglycemia is probably a reduction in the insulin response to glucose. Beta blockers also adversely affect blood sugar control but only by a small margin. The main cause for concern with beta blockers, however, is their effect during hypoglycemia in which nonselective agents delay blood sugar recovery. In diabetic patients, the institution of antihypertensive therapy should be followed by a reassessment to note any changes in sugar, potassium, and lipids, or side effects.
Copyright © 1985 by American Heart Association
Copyright © 1985 by American Heart Association
| Original language | English |
|---|---|
| Pages (from-to) | II95-II101 |
| Number of pages | 7 |
| Journal | Hypertension |
| Volume | 7 |
| Issue number | 6 pt. 2 |
| DOIs | |
| Publication status | Published - 7 Nov 1985 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Hypertension
- Hyperglycemia
- Hypokalemia
- Beta adrenergic receptor antagonists
Fingerprint
Dive into the research topics of 'Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver